Drug Shortage Report for VINCRISTINE SULFATE INJECTION
| Report ID | 246267 |
| Drug Identification Number | 02143305 |
| Brand name | VINCRISTINE SULFATE INJECTION |
| Common or Proper name | VINCRISTINE SULFATE INJECTION |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | VINCRISTINE SULFATE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 5ml |
| Anatomical Therapeutical Chemical (ATC) code | L01CA |
| Anatomical Therapeutical Chemical (ATC) description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-04-09 |
| Estimated end date | 2025-10-31 |
| Actual end date | 2025-10-22 |
| Shortage status | Resolved |
| Updated date | 2026-03-12 |
| Company comments | Equipment issue at MFG. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-01-09 | French | Compare |
| v3 | 2025-01-09 | English | Compare |
| v2 | 2024-12-20 | French | Compare |
| v1 | 2024-12-20 | English | Compare |